LYATK1 potently inhibits LPS-mediated pro-inflammatory response

Biochemical and Biophysical Research Communications

Volumn 470, Issue 1, 2016, Pages 1-8

  Xi, Feng ^a   Liu, Yuan ^b   Wang, Xiujuan ^a   Kong, Wei ^a   Zhao, Feng ^a  

^a TAIXING PEOPLE'S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

LPS; LYTAK1; Monocytes macrophages and inflammation; TAK1 signalings

Indexed keywords

CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE INHIBITOR; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN KINASE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL CULTURE; CELL LINE RAW 264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; EX VIVO STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEPTIC SHOCK; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELLULAR IMMUNITY; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; MONONUCLEAR CELL; RAW 264.7 CELL LINE; SHOCK, SEPTIC;

ADULT; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; PROTEIN KINASE INHIBITORS; RAW 264.7 CELLS; SHOCK, SEPTIC;

EID: 84956591965     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.090     Document Type: Article

References (31)

1. C. Nathan Points of control in inflammation Nature 420 2002 846 852
2. E. Nikoopour, J.A. Schwartz, and B. Singh Therapeutic benefits of regulating inflammation in autoimmunity Inflamm. Allerg. Drug Targets 7 2008 203 210
3. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759
4. S. Mariathasan, and D.M. Monack Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation Nat. Rev. Immunol. 7 2007 31 40
5. J. Vakkila, and M.T. Lotze Inflammation and necrosis promote tumour growth Nat. Rev. Immunol. 4 2004 641 648
6. S.I. Miller, R.K. Ernst, and M.W. Bader LPS, TLR4 and infectious disease diversity Nat. Rev. Microbiol. 3 2005 36 46
7. A. Aderem, and R.J. Ulevitch Toll-like receptors in the induction of the innate immune response Nature 406 2000 782 787
8. Z. Jiang, P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, M. Freudenberg, and B. Beutler CD14 is required for MyD88-independent LPS signaling Nat. Immunol. 6 2005 565 570
9. H. Sakurai Targeting of TAK1 in inflammatory disorders and cancer Trends Pharmacol. Sci. 33 2012 522 530
10. T. Irie, T. Muta, and K. Takeshige TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages FEBS Lett. 467 2000 160 164
11. A.A. Ajibade, H.Y. Wang, and R.F. Wang Cell type-specific function of TAK1 in innate immune signaling Trends Immunol. 34 2013 307 316
12. L. Dai, C. Aye Thu, X.Y. Liu, J. Xi, and P.C. Cheung TAK1, more than just innate immunity IUBMB Life 64 2012 825 834
13. J. Lee, L. Mira-Arbibe, and R.J. Ulevitch TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide J. Leukoc. Biol. 68 2000 909 915
14. W. Dong, Y. Liu, J. Peng, L. Chen, T. Zou, H. Xiao, Z. Liu, W. Li, Y. Bu, and Y. Qi The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4 J. Biol. Chem. 281 2006 26029 26040
15. D. Melisi, Q. Xia, G. Paradiso, J. Ling, T. Moccia, C. Carbone, A. Budillon, J.L. Abbruzzese, and P.J. Chiao Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 J. Natl. Cancer Inst. 103 2011 1190 1204
16. F. Meng, Y. Li, X. Tian, L. Fu, Y. Yin, C. Sui, P. Ma, and Y. Jiang Identification of TGF-beta-activated kinase 1 as a possible novel target for renal cell carcinoma intervention Biochem. Biophys. Res. Commun. 453 2014 106 111
17. L. Ying, Y. Chunxia, and L. Wei Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1 Cancer Chemother. Pharmacol. 76 2015 641 650
18. J. Zhou, B. Zheng, J. Ji, F. Shen, H. Min, B. Liu, J. Wu, and S. Zhang LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo Tumour Biol. 36 2015 3301 3308
19. S.L. Du, X. Yuan, S. Zhan, L.J. Tang, and C.Y. Tong Trametinib, a novel MEK kinase inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor (TNF)-alpha production and endotoxin shock Biochem. Biophys. Res. Commun. 458 2015 667 673
20. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
21. J.L. Zhang, Y. Xu, and J. Shen Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-alpha production via activating amp-activated protein kinase (AMPK) signaling Int. J. Mol. Sci. 15 2014 12119 12134
22. J. Zhu, C. Luo, P. Wang, Q. He, J. Zhou, and H. Peng Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-kappaB pathways in LPS-stimulated RAW 264.7 cells Exp. Ther. Med. 5 2013 1345 1350
23. M. Yu, D.T. Ting, S.L. Stott, B.S. Wittner, F. Ozsolak, S. Paul, J.C. Ciciliano, M.E. Smas, D. Winokur, A.J. Gilman, M.J. Ulman, K. Xega, G. Contino, B. Alagesan, B.W. Brannigan, P.M. Milos, D.P. Ryan, L.V. Sequist, N. Bardeesy, S. Ramaswamy, M. Toner, S. Maheswaran, and D.A. Haber RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis Nature 487 2012 510 513
24. H. Ding, T. Wang, D. Xu, B. Cha, J. Liu, and Y. Li Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation Biochem. Biophys. Res. Commun. 460 2015 157 163
25. A. Zecevic, H. Menard, V. Gurel, E. Hagan, R. DeCaro, and A. Zhitkovich WRN helicase promotes repair of DNA double-strand breaks caused by aberrant mismatch repair of chromium-DNA adducts Cell Cycle 8 2009 2769 2778
26. J. Ninomiya-Tsuji, T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, M. Shiina, M. Mihara, M. Tsuchiya, and K. Matsumoto A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase J. Biol. Chem. 278 2003 18485 18490
27. C.A. Leclair, M.B. Boxer, C.J. Thomas, and D.J. Maloney Total synthesis of LL-Z1640-2 utilizing a late-stage intramolecular Nozaki-Hiyama-Kishi reaction Tetrahedron Lett. 51 2010 6852 6855
28. E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, A. Lembo, C. Kalis, and M. Gumenscheimer The role of the liver in the response to LPS: experimental and clinical findings J. Endotoxin Res. 8 2002 319 327
29. C.D. Dumitru, J.D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J.H. Lin, C. Patriotis, N.A. Jenkins, N.G. Copeland, G. Kollias, and P.N. Tsichlis TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway Cell 103 2000 1071 1083
30. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat. Rev. Immunol. 2 2002 725 734
31. Y. Bordon Inflammation: TNF snuffs out steroids Nat. Rev. Immunol. 14 2014 214